You have read all your free articles, to continue reading subscribe to read the rest of this content.
As many as 96 percent of those infected with COVID-19 retain protective antibodies for at least nine months after confirmed infection. This is shown by a study from Danderyd Hospital and Karolinska Institutet using antibody tests developed by researchers at KTH and the SciLifeLab Autoimmunity ProAlready a subscriber Login You…
With the latest grants, the Novo Nordisk Foundation has awarded a total of DKK 74.9 million for 43 projects which may help to mitigate the health-related consequences of the COVID-19 epidemic in Denmark. The Novo Nordisk Foundation announces six new grants for coronavirus-related projects across Already a subscriber Login You…
Interim results from the ongoing Phase II/III COV002 trial of AZD1222 in the UK, led by the University of Oxford, demonstrated lower local and systemic reactions in older adults (≥56-69 years and ≥70 years) than younger adults (≥18-55 years) and generated similar robust immune responses againsAlready a subscriber Login You…
Researchers have developed new small antibodies, nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells. In a new study, published in Science, researchers from Karolinska Institutet in collaboration with researchers at the University of Bonn in Germany and the Scripps ReAlready a subscriber Login You have read all your free articles,…
